Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure
Open Access
- 1 February 2004
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 41 (2), 13e-13
- https://doi.org/10.1136/jmg.2003.011536
Abstract
Malignant melanoma (MM) is increasing in most Caucasian populations, the incidence doubling every 10 years.1 Multiple phenotypic risk factors, including the number of melanocytic naevi (moles), freckling, dysplastic naevi, propensity to sunburn, and the number of severe sunburn episodes during youth, have been identified in the aetiology and pathogenesis of this disease.2 Approximately 10% of MM cases occur in kindreds, suggesting hereditary predisposition to melanoma, often in association with the atypical mole syndrome (AMS) phenotype. Germline mutations affecting two highly penetrant genes predisposing to melanoma, CDKN2A and Cdk4 , have been associated with an increased risk for the development of familial cutaneous melanoma.3–6 However, these mutations are found in only 30 to 40% of kindreds, indicating that other genes may predispose to MM. In addition to the major predisposition to melanoma caused by these genes, polygenic inheritance determining the development of melanoma has been shown to depend upon polymorphisms located on genes controlling different cellular pathways such as DNA repair,7 pigmentation,8 and reactive oxygen detoxification.9,10 Among these, loss of function variants of the human melanocortin 1 receptor gene ( MC1R ), which plays a crucial role in pigmentation,11,12 seems important in determining MM risk.8,13 MC1R maps to chromosome 16q24.3 and encodes a G protein coupled receptor with seven transmembrane domains expressed on many cell types,14 including melanocytes. MC1R is the receptor of two melanocortin peptides synthesised in the pituitary gland, alpha melanocyte stimulating hormone (α-MSH) and ACTH. These have the same affinity for MC1R , and are cleavage products of the large precursor peptide propiomelanocortin. Their binding to this receptor activates adenylate cyclase, increases intracellular c-AMP production, then leads to enhanced tyrosinase transcription and traduction, and, ultimately, to production of photoprotective eumelanin and melanocyte proliferation. Regulation of melanogenesis also …Keywords
This publication has 36 references indexed in Scilit:
- Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrixOncogene, 2002
- Skin colour and skin cancer –MC1R, the genetic linkMelanoma Research, 2002
- Thr40 and Met122 are new partial loss‐of‐function natural mutations of the human melanocortin 1 receptorFEBS Letters, 2001
- The Relation Between Melanocortin 1 Receptor Genotype and Experimentally Assessed Ultraviolet Radiation SensitivityJournal of Investigative Dermatology, 2001
- New aspects on the melanocortins and their receptorsPharmacological Research, 2000
- Oxidative Stress Regulates the Interaction of p16 with Cdk4Biochemical and Biophysical Research Communications, 2000
- Evidence for Variable Selective Pressures at MC1RAmerican Journal of Human Genetics, 2000
- Melanocortin-1 Receptor Polymorphisms and Risk of Melanoma: Is the Association Explained Solely by Pigmentation Phenotype?American Journal of Human Genetics, 2000
- Loss of Function Mutations of the Human Melanocortin 1 Receptor Are Common and Are Associated with Red HairBiochemical and Biophysical Research Communications, 1999
- Human Pigmentation Phenotype: A Point Mutation Generates Nonfunctional MSH ReceptorBiochemical and Biophysical Research Communications, 1998